Subtype
Hepatocellular Carcinoma
CI-CAN-00002853HCC · LIHCExplore in graph →
693 active trials13 approved drugs9 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002853HCC · LIHCExplore in graph →
Clinical trials
3,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (357)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02599909 | Gut Microbiota in People With Hepatocellular Carcinoma (HCC) | withdrawn | — | 0 | National Cancer Institute (NCI)NIH | 0 | Sep 20, 2018 | clinicaltrials |
| NCT02743065 | HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China(SUPER-China) | unknown | — | 100 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Sep 20, 2018 |
| clinicaltrials |
| NCT03672305 | Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC | unknown | Early Phase 1 | 50 | The Second Hospital of Nanjing Medical UniversityOTHER | 0 | Sep 18, 2018 | clinicaltrials |
| NCT01409499 | Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC)(2011PTAHCC) | completed | Phase 4 | 180 | Sun Yat-sen UniversityOTHER | 1 | Sep 11, 2018 | clinicaltrials |
| NCT02967523 | Surefire Precision Infusion System Registry | terminated | — | 111 | Surefire Medical, Inc.INDUSTRY | 1 | Sep 11, 2018 | clinicaltrials |
| NCT03345225 | A Clinical Study of Precision TACE (P-TACE) With Surefire | withdrawn | N/A | 0 | University of MiamiOTHER | 1 | Sep 11, 2018 | clinicaltrials |
| NCT00357422 | Comparison Study of Operation and PEIT for Small, Solitary Hepatocellular Carcinoma (HCC) | completed | N/A | 36 | Seoul National University HospitalOTHER | 1 | Sep 10, 2018 | clinicaltrials |
| NCT03005756 | Needle Guiding Robot for Radiofrequency Ablation: Safety and Efficacy Study on Hepatocellular Carcinoma Patients(NGR) | unknown | N/A | 20 | Asan Medical CenterOTHER | 1 | Sep 10, 2018 | clinicaltrials |
| NCT02006030 | Ph 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Vs TACE Alone in Patients With Unresectable Hepatocellular Carcinoma(TACE) | completed | Phase 2 | 30 | Polaris GroupINDUSTRY | 1 | Sep 4, 2018 | clinicaltrials |
| NCT03652896 | Anatomy-based Resection or Margin-based Resection for Hepatocellular Carcinoma | unknown | N/A | 60 | Huazhong University of Science and TechnologyOTHER | 1 | Aug 29, 2018 | clinicaltrials |
| NCT01643824 | Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma | completed | N/A | 112 | National Cancer Center, KoreaOTHER_GOV | 1 | Aug 23, 2018 | clinicaltrials |
| NCT01425996 | A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma | terminated | Phase 1 / Phase 2 | 3 | Taiwan Liposome CompanyINDUSTRY | 1 | Aug 21, 2018 | clinicaltrials |
| NCT02293850 | Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma | unknown | Phase 1 | 18 | Oncolys BioPharma IncINDUSTRY | 2 | Aug 20, 2018 | clinicaltrials |
| NCT03636620 | TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial(TACE+RFA) | completed | Phase 3 | 110 | Fudan UniversityOTHER | 1 | Aug 17, 2018 | clinicaltrials |
| NCT00692770 | Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)(STORM) | completed | Phase 3 | 1,114 | BayerINDUSTRY | 28 | Aug 8, 2018 | clinicaltrials |
| NCT02138981 | Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria | unknown | Phase 4 | 436 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT02848638 | Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 Radioembolization(PET-Y90) | completed | — | 35 | University of WashingtonOTHER | 0 | Aug 2, 2018 | clinicaltrials |
| NCT03469479 | Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria | unknown | Phase 3 | 252 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT03609151 | Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular Carcinoma | unknown | N/A | 110 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 1, 2018 | clinicaltrials |
| NCT03609268 | Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma | unknown | N/A | 110 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 1, 2018 | clinicaltrials |
| NCT01528878 | Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases | completed | N/A | 30 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT03594929 | Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery | unknown | N/A | 50 | Singapore General HospitalOTHER | 1 | Jul 20, 2018 | clinicaltrials |
| NCT02057874 | 3-Tesla MRI Response to TACE in HCC (Liver Cancer) | terminated | N/A | 2 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 11, 2018 | clinicaltrials |
| NCT02678806 | Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion(RHCC:BCLC-A) | unknown | N/A | 620 | Guangxi Medical UniversityOTHER | 1 | Jul 10, 2018 | clinicaltrials |
| NCT00832637 | Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers(Gem-ox) | terminated | Phase 2 | 33 | New Mexico Cancer Research AllianceOTHER | 1 | Jun 29, 2018 | clinicaltrials |
| NCT01502410 | Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer | completed | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 3 | Jun 26, 2018 | clinicaltrials |
| NCT03168152 | Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular Carcinoma | withdrawn | N/A | 0 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 25, 2018 | clinicaltrials |
| NCT02748161 | DEB-TACE for Hepatocellular Carcinoma(QED) | terminated | N/A | 170 | Surefire Medical, Inc.INDUSTRY | 1 | Jun 21, 2018 | clinicaltrials |
| NCT01352728 | Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib | completed | Phase 2 | 50 | Chinese University of Hong KongOTHER | 1 | Jun 20, 2018 | clinicaltrials |
| NCT02702960 | Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC) | withdrawn | Phase 2 | 0 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 15, 2018 | clinicaltrials |
| NCT03129685 | Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma(NRU) | unknown | N/A | 12 | The National Ribat UniversityOTHER | 1 | Jun 12, 2018 | clinicaltrials |
| NCT03551444 | Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial(CAUTIOUS) | unknown | Phase 3 | 80 | Ain Shams UniversityOTHER | 1 | Jun 11, 2018 | clinicaltrials |
| NCT00906373 | A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver | completed | Phase 2 | 47 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 4, 2018 | clinicaltrials |
| NCT01681446 | Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression | unknown | Phase 3 | 296 | Fudan UniversityOTHER | 1 | Jun 1, 2018 | clinicaltrials |
| NCT03534843 | A Comparison Between Child-Pugh and Albumin-Bilirubin Scores | completed | — | 230 | Huazhong University of Science and TechnologyOTHER | 0 | May 29, 2018 | clinicaltrials |
| NCT01834963 | P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma. | unknown | Phase 2 | 66 | Kansai Hepatobiliary Oncology GroupNETWORK | 1 | May 18, 2018 | clinicaltrials |
| NCT02690350 | An Open Study Assessing the Safety and Tolerability of U3-1784 | terminated | Phase 1 | 10 | Daiichi SankyoINDUSTRY | 1 | May 16, 2018 | clinicaltrials |
| NCT01259024 | The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead | terminated | N/A | 1 | Washington University School of MedicineOTHER | 1 | May 15, 2018 | clinicaltrials |
| NCT02021253 | Influence of Probiotics Administration Before Liver Resection in Liver Disease(LIPROCES) | completed | N/A | 64 | University Hospital, RouenOTHER | 1 | May 15, 2018 | clinicaltrials |
| NCT03515252 | Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer | completed | Phase 1 | 20 | Ivy Life Sciences, Co., LtdINDUSTRY | 0 | May 9, 2018 | clinicaltrials |
| NCT03520257 | The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus | unknown | Phase 2 | 50 | Guangxi Medical UniversityOTHER | 0 | May 9, 2018 | clinicaltrials |
| NCT03518502 | Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis | unknown | Phase 4 | 130 | Korea UniversityOTHER | 1 | May 8, 2018 | clinicaltrials |
| NCT03516448 | Expanding Phase III Study of Tyroserleutide for Injection | unknown | Phase 3 | 352 | Shenzhen Kangzhe Pharmaceutical Co., Ltd.INDUSTRY | 0 | May 4, 2018 | clinicaltrials |
| NCT03516890 | Management of Spontaneous Ruptured Hepatocellular Carcinoma | completed | — | 216 | Huazhong University of Science and TechnologyOTHER | 0 | May 4, 2018 | clinicaltrials |
| NCT03515369 | Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma | unknown | Phase 4 | 459 | Eastern Hepatobiliary Surgery HospitalOTHER | 0 | May 3, 2018 | clinicaltrials |
| NCT03285867 | Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma | unknown | — | 200 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | Apr 30, 2018 | clinicaltrials |
| NCT03511703 | The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients | unknown | Phase 2 | 40 | Guangxi Medical UniversityOTHER | 0 | Apr 30, 2018 | clinicaltrials |
| NCT02188901 | Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional Study | completed | N/A | 523 | Yonsei UniversityOTHER | 1 | Apr 26, 2018 | clinicaltrials |
| NCT01665937 | STA-9090 in Patients With Advanced Hepatocellular Cancer | completed | Phase 1 | 16 | Massachusetts General HospitalOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT01962649 | A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green | completed | Early Phase 1 | 20 | Massachusetts General HospitalOTHER | 1 | Apr 25, 2018 | clinicaltrials |
Data updated 24 days agoSource updated Sep 20, 2018source: clinicaltrials